COMMUNIQUÉS West-GlobeNewswire
-
Dyadic Applied BioSolutions Announces Participation in Sidoti Virtual Investor Conference
19/05/2026 -
BioSyent annonce l’approbation de Thyconvi(MD) par Santé Canada (solution orale de lévothyroxine)
19/05/2026 -
BioSyent Announces Health Canada Approval of Thyconvi™ (levothyroxine oral solution)
19/05/2026 -
Enspire Dental Launches New Emergency Care Initiative to Assist Ann Arbor Families During Dental Crises
19/05/2026 -
Capra Biosciences Launches Bioproduced Salicylic Acid for Personal Care at NYSCC Suppliers’ Day
19/05/2026 -
NeOnc Technologies Gains Growing Institutional Support Ahead of Key Brain Cancer Clinical Milestones
19/05/2026 -
Atos Selected by Viasat to Modernize Global Digital Workplace Operations
19/05/2026 -
Nord Pilates Surpasses 1,300 Customer Reviews as Women Praise Personalized Pilates Plans and Low-Impact Home Workouts
19/05/2026 -
XORTX Announces Closing of US$5 Million Public Offering
19/05/2026 -
Amplia Therapeutics Launches First Stage of Registration-Enabling Trial of Narmafotinib
19/05/2026 -
Propanc Biopharma Engages European CDMO for GMP Production of PRP for Phase 1b, FIH Study in 30 – 40 Advanced Cancer Patients
19/05/2026 -
Oragenics to Present at Sidoti’s Micro-Cap Virtual Investor Conference May 20-21
19/05/2026 -
Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial
19/05/2026 -
Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference
19/05/2026 -
Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation
19/05/2026 -
HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network
19/05/2026 -
RenovoRx to Present at the Alliance Global Partners Virtual Annual Healthcare Company Showcase on May 20th
19/05/2026 -
Prana IV Therapy Highlights Emerging Research on Magnesium’s Role in Stress and Neurological Function
19/05/2026 -
Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease
19/05/2026
Pages